ACC 2018Acute Coronary SyndromeConferences ODYSSEY Outcomes: Alirocumab Reduces MACE, Non-fatal MI, Ischemic Stroke, and All-Cause Mortality in ACS Patients Tarek Nafee, M.D. Share 0 Min Read http://cardiologynownews.org/wp-content/uploads/2018/03/sun_945_schwartz.mp4 TAGGED:Featured Share This Article Copy Link Print Leave a Comment Leave a Reply Cancel replyYou must be logged in to post a comment.
